Related Experiment Video
Updated: Aug 30, 2026

Hand-Rearing Method for Infant Marmosets
Published on: June 9, 2023
[Child feeding and diarrhea morbidity]
Graciete O Vieira1, Luciana R Silva, Tatiana de O Vieira
1Universidade Estadual de Feira de Santana. graciete.vieira@terra.com.br
Objective:
To evaluate the protective role of breastfeeding against diarrhea in children younger than one year of age in the city of Feira de Santana, Brazil, in 2001.
Methods:
A cross-sectional study was carried out. Questionnaires were applied to mothers by 104 university students on the national vaccination day in 44 health units (71.0%) selected by simple stratification. 2,319 children were evaluated (24.3% of the estimated population). The prevalence ratio was calculated and considered significant if p< or =0.05 with a 95% confidence interval.
Results:
Diarrhea occurred in 11.6% of the sample, with greater frequency after the sixth month (63.3%). The chance for presenting diarrhea was 64% higher in children younger than six months who were not breastfed vs. breastfed children (p<0.02). When compared to the children who were exclusively breastfed, the chance for presenting diarrhea increased to 82% in children who were not breastfed (95% CI 1.11-3.01).
Conclusions:
Breastfeeding and exclusive breastfeeding were a protective factor against diarrhea in the first six months of life.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Giardiasis
Bacterial Gastroenteritis
Cholera
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
